Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William H Bullock

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Critical Reviews in Toxicology|September 17, 2020
Perspectives on the knowledge of asbestos disease in the United States - what was known, by whom, and whenWilliam H Bullock
Journal of Occupational and Environmental Hygiene|March 20, 2014
Rating locomotive crew diesel emission exposure profiles using statistics and Bayesian Decision AnalysisPaul Hewett, William H Bullock
Risk Analysis : an Official Publication of the Society for Risk Analysis|August 11, 2015
Characterizing and Communicating Risk with Exposure Reconstruction and Bayesian Analysis: Historical Locomotive Maintenance/Repair Associated with Asbestos Woven Tape Pipe LaggingFred W Boelter, Jacob D Persky, Daniel M Podraza, et al.
Current Topics in Medicinal Chemistry|August 13, 2002
Prospects for kinase activity modulators in the treatment of diabetes and diabetic complicationsWilliam H Bullock, Steven R Magnuson, Soongyu Choi, et al.
ACS Combinatorial Science|August 23, 2012
Addressing the medicinal chemistry bottleneck: a lean approach to centralized purificationHarold N Weller, David S Nirschl, James L Paulson, et al.
Journal of Medicinal Chemistry|February 6, 2007
Indanylacetic acid derivatives carrying 4-thiazolyl-phenoxy tail groups, a new class of potent PPAR alpha/gamma/delta pan agonists: synthesis, structure-activity relationship, and in vivo efficacyJoachim Rudolph, Libing Chen, Dyuti Majumdar, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
In vitro SAR of (5-(2H)-isoxazolonyl) ureas, potent inhibitors of hormone-sensitive lipaseDerek B Lowe, Steven Magnuson, Ning Qi, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2006
Indanylacetic acid derivatives carrying aryl-pyridyl and aryl-pyrimidinyl tail groups--new classes of PPAR gamma/delta and PPAR alpha/gamma/delta agonistsLouis-David Cantin, Sidney Liang, Herbert Ogutu, et al.
Bioorganic & Medicinal Chemistry Letters|November 9, 2005
Substituted indanylacetic acids as PPAR-alpha-gamma activatorsDerek B Lowe, Neil Bifulco, William H Bullock, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2007
PDE-10A inhibitors as insulin secretagoguesLouis-David Cantin, Steven Magnuson, David Gunn, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Critical Reviews in Toxicology|September 17, 2020
Perspectives on the knowledge of asbestos disease in the United States - what was known, by whom, and whenWilliam H Bullock
Journal of Occupational and Environmental Hygiene|March 20, 2014
Rating locomotive crew diesel emission exposure profiles using statistics and Bayesian Decision AnalysisPaul Hewett, William H Bullock
Risk Analysis : an Official Publication of the Society for Risk Analysis|August 11, 2015
Characterizing and Communicating Risk with Exposure Reconstruction and Bayesian Analysis: Historical Locomotive Maintenance/Repair Associated with Asbestos Woven Tape Pipe LaggingFred W Boelter, Jacob D Persky, Daniel M Podraza, et al.
Current Topics in Medicinal Chemistry|August 13, 2002
Prospects for kinase activity modulators in the treatment of diabetes and diabetic complicationsWilliam H Bullock, Steven R Magnuson, Soongyu Choi, et al.
ACS Combinatorial Science|August 23, 2012
Addressing the medicinal chemistry bottleneck: a lean approach to centralized purificationHarold N Weller, David S Nirschl, James L Paulson, et al.
Journal of Medicinal Chemistry|February 6, 2007
Indanylacetic acid derivatives carrying 4-thiazolyl-phenoxy tail groups, a new class of potent PPAR alpha/gamma/delta pan agonists: synthesis, structure-activity relationship, and in vivo efficacyJoachim Rudolph, Libing Chen, Dyuti Majumdar, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
In vitro SAR of (5-(2H)-isoxazolonyl) ureas, potent inhibitors of hormone-sensitive lipaseDerek B Lowe, Steven Magnuson, Ning Qi, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2006
Indanylacetic acid derivatives carrying aryl-pyridyl and aryl-pyrimidinyl tail groups--new classes of PPAR gamma/delta and PPAR alpha/gamma/delta agonistsLouis-David Cantin, Sidney Liang, Herbert Ogutu, et al.
Bioorganic & Medicinal Chemistry Letters|November 9, 2005
Substituted indanylacetic acids as PPAR-alpha-gamma activatorsDerek B Lowe, Neil Bifulco, William H Bullock, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2007
PDE-10A inhibitors as insulin secretagoguesLouis-David Cantin, Steven Magnuson, David Gunn, et al.
Pageof 2